Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Public Health (Oxf) ; 43(2): e389-e390, 2021 06 07.
Artículo en Inglés | MEDLINE | ID: mdl-33783540

RESUMEN

The Coronavirus disease 2019 (COVID-19) vaccination hesitancy is a concern that the world faces. The government and private sectors are initiating measures to address this problem. Media plays a crucial role in information and extensive dissemination. This paper highlights the role of the agenda setting platform in shaping public opinion on COVID-19 vaccination program. Massive information dissemination through media can be an effective tool in educating the public regarding the efficacy of anti-COVID 19 vaccines both for self-preservation and promotion of the common good.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Humanos , Opinión Pública , SARS-CoV-2 , Vacunación
2.
ScientificWorldJournal ; 2012: 607498, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22701364

RESUMEN

Cerebrovascular disease is the third leading cause of death and the leading cause of disability in Cuba and in several developed countries. A possible neuroprotective agent is the rHu-EPO, whose effects have been demonstrated in models of brain ischemia. The Neuro-EPO is a derivative of the rHu-EPO that avoids the stimulation of erythropoiesis. The aim of this study was to determine the Neuro-EPO delivery into the central nervous system (CNS) to exert a neuroprotective effect in cerebral ischemia model of the Mongolian gerbil. The Neuro-EPO in a rate of 249.4 UI every 8 hours for 4 days showed 25% higher viability efficacy (P > 0.01), improving neurological score and behavior of the spontaneous exploratory activity, the preservation of CA3 areas of the hippocampus, the cortex, and thalamic nuclei in the focal ischemia model of the Mongolian gerbil. In summary, this study, the average dose-used Neuro-EPO (249.4 UI/10 µL/every 8 hours for 4 days), proved to be valid indicators of viability, neurological status, and spontaneous exploratory activity, being significantly lower than that reported for the systemically use of the rHu-EPO as a neuroprotectant. Indeed, up to 12 h after brain ischemia is very positive Neuro-EPO administration by the nasal route as a candidate for neuroprotection.


Asunto(s)
Isquemia Encefálica/tratamiento farmacológico , Isquemia Encefálica/prevención & control , Eritropoyetina/administración & dosificación , Fármacos Neuroprotectores/administración & dosificación , Administración Intranasal , Animales , Isquemia Encefálica/diagnóstico , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Gerbillinae , Humanos , Resultado del Tratamiento
3.
J Pediatr Psychol ; 32(1): 24-9, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-16861704

RESUMEN

OBJECTIVE: The goal of this study was to evaluate peer-related influences on appearance, body dissatisfaction, eating disturbance, and self-esteem in average weight, at risk of overweight, and overweight adolescent girls. METHODS: Three hundred twenty-five adolescent girls from high schools in Florida were assessed. Ninety met criteria for being at risk of overweight or overweight. Logistic and multiple regression analyses were used to evaluate group differences on all variables and to assess the amount of variance accounted for by peer-influence variables in the prediction of body dissatisfaction, eating disturbance, and self-esteem. RESULTS: Overweight and at risk of overweight girls scored higher than average weight girls on body dissatisfaction, dieting, and a peer measure that assessed negative comments and attributions about appearance. They also scored lower than average weight girls on self-report measures that assessed conversations about appearance and anti-dieting advice. How influential friends were in determining one's body image was a unique predictor of body dissatisfaction but only for the overweight and at risk of overweight group. CONCLUSIONS: Possible implications for clinical intervention programs are discussed along with directions for future research.


Asunto(s)
Peso Corporal , Relaciones Interpersonales , Obesidad/epidemiología , Obesidad/psicología , Grupo Paritario , Autoimagen , Trastornos Somatomorfos/diagnóstico , Trastornos Somatomorfos/epidemiología , Adolescente , Femenino , Humanos , Factores de Riesgo , Deseabilidad Social , Trastornos Somatomorfos/psicología , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA